|
gptkb:GAA_gene
|
available
|
|
gptkb:H3B-8800
|
Phase 1
|
|
gptkb:Nkarta_Therapeutics
|
NKX101 for acute myeloid leukemia (AML)
|
|
gptkb:IM-99
|
gptkb:Phase_I
|
|
gptkb:GDC-0068
|
Phase III
|
|
gptkb:PRLR
|
prolactin receptor antibody test
|
|
gptkb:NVX-CoV2373
|
gptkb:South_Africa
|
|
gptkb:epacadostat
|
Phase III (as of 2018)
|
|
gptkb:MK-0826
|
Phase III (terminated)
|
|
gptkb:COVID-19_vaccine_development_(Moderna)
|
Phase 3
|
|
gptkb:CK-1827452
|
Phase 3
|
|
gptkb:von_Willebrand_factor
|
VWF antigen assay
|
|
gptkb:HRAS_gene
|
HRAS mutation analysis
|
|
gptkb:SPT-615
|
Phase 3
|
|
gptkb:TAXUS_V
|
NCT00177638
|
|
gptkb:Cerevel_Therapeutics
|
Alzheimer's disease psychosis
|
|
gptkb:OKB-301
|
Phase 1
|
|
gptkb:Ventyx_Biosciences
|
Phase 2 (VTX2735)
|
|
gptkb:AZD2281
|
Phase III
|
|
gptkb:ProLon_fasting-mimicking_diet
|
yes
|